C48.2
Malignant neoplasm of peritoneum, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the peritoneum, classified under ICD-10 code C48.2, is a rare type of cancer that affects the peritoneum—a thin layer of tissue lining the abdominal cavity and covering abdominal organs. Although it is called 'unspecified,' this diagnosis indicates that the exact location or type of the tumor within the peritoneum has not been identified. Recognizing the signs and understanding the nature of this cancer can be essential for early diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic predispositions, such as mutations in specific genes Previous exposure to radiation or certain carcinogenic substances History of other abdominal or pelvic cancers Chronic inflammation or irritation of the peritoneal lining In some cases, idiopathic, where no clear cause is identified
Key Symptoms: Abdominal pain or discomfort, often persistent or worsening Abdominal swelling or bloating Unexplained weight loss Early satiety or feeling full quickly Nausea or vomiting Changes in bowel habits, such as constipation or diarrhea Fatigue or general weakness Ascites, which is the accumulation of fluid in the abdominal cavity
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm of the peritoneum involves a combination of clinical evaluation and diagnostic tests, including: - Imaging studies such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and ultrasounds to visualize abnormal growths or fluid accumulation - Biopsy procedures to obtain tissue samples for histopathological examination - Blood tests that can indicate inflammation or tumor markers, although they are not definitive - Exploratory surgery in some cases, especially when imaging results are inconclusive The goal of these diagnostic procedures is to confirm the presence of malignancy and to determine the extent or stage of the disease.
Treatment Protocols: Managing malignant neoplasm of the peritoneum typically involves a multidisciplinary approach, including: - Surgery to remove visible tumors and affected tissues when feasible - Chemotherapy to target cancer cells systemically, often used in conjunction with surgery - Radiation therapy, although its role is limited due to the sensitivity of surrounding tissues - Targeted therapy and immunotherapy are emerging options that may be considered depending on the tumor characteristics and genetic profile - Palliative care aimed at relieving symptoms and improving quality of life, especially in advanced stages Treatment plans are tailored to individual patient factors, including overall health, tumor extent, and response to therapy.
Clinical Advice & FAQs
Billing Guidance
Is C48.2 a billable ICD-10 code?
Yes, C48.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C48.2?
Clinical documentation must specify the nature of Malignant neoplasm of peritoneum, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference